JULY 1, 2021
Grants Awarded

Extramurally funded research grants awarded to Rogel Cancer Center members

Program Key:
CB - Cancer Biology; CG - Cancer Genetics; CHI - Cancer Hematopoiesis and Immunology; DT - Developmental Therapeutics; HBO - Health Behavior and Outcomes; CEP - Cancer Epidemiology and Prevention; TACR - Translational and Clinical Research
In the Spotlight
The Damon Runyon Cancer Research Foundation awarded two Rogel Cancer Center members:

Phillip Palmbos, M.D., Ph.D.: $600K for “Targeting TRIM29 to Reverse Immune Checkpoint Inhibitor Resistance in Bladder Cancer” (CB)

Daniel Wahl, M.D., Ph.D.: $600K for “Targeting metabolic interactions in the glioblastoma microenvironment to overcome therapy resistance” (DT)

The American Cancer Society awarded Daniel Hertz, PharmD, Ph.D., $634K for “Nutrient Insufficiency and Peripheral Neuropathy Risk-Second Resubmission.” (TACR)
$100K+ Extramural Grants Awarded in March
NCI

Lynn Henry, M.D., Ph.D.: R21 ($350K) for "Inflammatory oxylipins and aromatase inhibitor toxicity in breast cancer" (CCPS)

Michael Green, M.D., Ph.D.: R21 ($257K) for “Targeting BUB 1 for radio- and immuno-sensitization of triple negative breast cancer (TNBC)” (CHI)

Zhen Xu, Ph.D.: R21 ($257K) for “Non-invasive transcranial histotripsy treatment in a murine primary malignant brain tumor model” (DT)

Other NIH

Ken Resnicow, Ph.D., and Erica Marsh, M.D.: R01 for “Community-Centered interventions for improved vaccine uptake for COVID (CIVIC)” (CCPS)

Rahasudha Kannan (mentor: Laurie McCauley, D.D.S., Ph.D.): F31 ($123K) for “Biomimetic apoptotic particles for macrophage-driven oral bone regeneration” (CB)

Other NIH

Sriram Venneti, M.D., Ph.D.: $600K from the Michael Mosier Defeat DIPG Foundation for "Metabolic therapies for DIPGs" (CG)

Isabelle Lombaert, Ph.D.: $175K from the American Cancer Society for “The role of neutrophil-derived nucleoprotein in tumor growth and metastasis” (CB)

Maria Castro, Ph.D., and Pedro Lowenstein, Ph.D.: $125K from the Ian's Friends Foundation for “Tumor targeting of nanoparticles as therapeutic siRNA carriers for pediatric high grade gliomas (phGG)” (CHI)

Internal Awards

Matthew Schipper, Ph.D.: $100K Rogel Cancer Center Catchment Area grant for "Validation of progression and toxicity biomarkers in lung cancer" (TACR)

Aaron Udager, M.D.: $100K Rogel Cancer Center Catchment Area grant for "Single cell analysis of intratumoral heterogeneity and neoadjuvant chemotherapy response in muscle-invasive bladder cancer" (TACR)

Debbie Chen, M.D.: $75K Rogel Cancer Center Discovery grant for “Disparities in access to cancer care for simulated patients with limited English proficiency” (CCPS)

Evan Keller, DVM, Ph.D.: $75K Rogel Cancer Center Discovery grant for “Evaluation of prostate biopsy spatial multiomics to improve grading accuracy” (CB)
Rogel Cancer Center List of Internal and External Funding Opportunities
We update and maintain a comprehensive list of funding opportunities for cancer research.

Please forward this message to your fellow cancer center colleagues.
M-LINE 800-962-3555 | HEALTH LAB BLOG ROGEL CANCER CENTER INTRANET